1,331
Views
1
CrossRef citations to date
0
Altmetric
HPV – Research Article

Human papillomavirus vaccine uptake among teens before and during the COVID-19 pandemic in the United States

, , , , , & ORCID Icon show all
Article: 2148825 | Received 16 Sep 2022, Accepted 13 Nov 2022, Published online: 09 Dec 2022

References

  • Kreisel KM, Spicknall IH, Gargano JW, Lewis FMT, Lewis RM, Markowitz LE, Roberts H, Johnson AS, Song R, St Cyr SB. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018. Sex Transm Dis. 2021;48(4):208–8. doi:10.1097/OLQ.0000000000001355.
  • Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman A, Unger ER, Williams A, Iskander J. CDC grand rounds: reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep. 2014;63:69.
  • Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus–associated cancers—United States, 1999–2015. Morb Mort Wkly Rep. 2018;67(33):918. doi:10.15585/mmwr.mm6733a2.
  • Osazuwa-Peters N, Graboyes EM, Khariwala SS. Expanding Indications for the human papillomavirus vaccine: one small step for the prevention of head and neck cancer, but one giant leap remains. JAMA Otolaryngol Head Neck Surg. 2020 Dec 1;146(12):1099–101. doi:10.1001/jamaoto.2020.4068.
  • McLendon L, Puckett J, Green C, James J, Head KJ, Yun Lee H, Young Pierce J, Beasley M, Daniel CL. Factors associated with HPV vaccination initiation among United States college students. Hum Vaccines Immunother. 2021;17(4):1033–43. doi:10.1080/21645515.2020.1847583.
  • Centers for Disease Control and Prevention. HPV vaccine. [accessed 2021 Jan 27]. https://www.cdc.gov/hpv/parents/vaccine-for-hpv.html#::text=Children%20ages%2011%E2%80%9312%20years,doses%2C%20given%20over%206%20months.
  • US Department of Health and Human Services. Healthy people 2020 topics & objectives: immunization and infectious diseases. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives.
  • Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Williams CL, Fredua B, McNamara LA, Stokley S, Singleton JA. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2020. MMWR Morb Mortal Wkly Rep. 2021 Sep 3;70(35):1183–90. doi:10.15585/mmwr.mm7035a1.
  • Rambout L, Tashkandi M, Hopkins L, Tricco AC. Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review. Prev Med. 2014 Jan;58:22–32. doi:10.1016/j.ypmed.2013.10.009.
  • Downs LS Jr, Scarinci I, Einstein MH, Collins Y, Flowers L. Overcoming the barriers to HPV vaccination in high-risk populations in the US. Gynecol Oncol. 2010 Jun;117(3):486–90. doi:10.1016/j.ygyno.2010.02.011.
  • Sonawane K, Lin YY, Damgacioglu H, Zhu Y, Fernandez ME, Montealegre JR, Cazaban CG, Li R, Lairson DR, Lin Y, et al. Trends in human papillomavirus vaccine safety concerns and adverse event reporting in the United States. JAMA Netw Open. 2021 Sep 1;4(9):e2124502. doi:10.1001/jamanetworkopen.2021.24502.
  • Maness SB, Thompson EL. Social determinants of human papillomavirus vaccine uptake: an assessment of publicly available data. Public Health Rep. 2019 May/Jun;134(3):264–73. doi:10.1177/0033354919838219.
  • Thompson EL, Rosen BL, Maness SB. Social determinants of health and human papillomavirus vaccination among young adults, national health interview survey 2016. J Community Health. 2019 Feb;44(1):149–58. doi:10.1007/s10900-018-0565-2.
  • Webb Hooper M, Nápoles AM, Pérez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA. 2020 Jun 23;323(24):2466–67. doi:10.1001/jama.2020.8598.
  • Menon DU, Belcher HME. COVID-19 pandemic health disparities and pediatric health care-the promise of telehealth. JAMA Pediatr. 2021 Apr 1;175(4):345–46. doi:10.1001/jamapediatrics.2020.5097.
  • Osazuwa-Peters N, Rohde RL, Adjei Boakye E. HPV vaccination is safe-you don’t have to whisper it. JAMA Netw Open. 2021 Sep 1;4(9):e2125124. doi:10.1001/jamanetworkopen.2021.25124.
  • Gilkey MB, Bednarczyk RA, Gerend MA, Kornides ML, Perkins RB, Saslow D, Sienko J, Zimet GD, Brewer NT. Getting human papillomavirus vaccination back on track: protecting our national investment in human papillomavirus vaccination in the COVID-19 era. J Adolesc Health. 2020 Nov;67(5):633–34. doi:10.1016/j.jadohealth.2020.08.013.
  • Toh ZQ, Russell FM, Garland SM, Mulholland EK, Patton G, Licciardi PV. Human papillomavirus vaccination after COVID-19. JNCI Cancer Spectr. 2021 Apr;5(2):kab011. doi:10.1093/jncics/pkab011.
  • Moreland A, Herlihy C, Tynan MA, Sunshine G, McCord RF, Hilton C, Poovey J, Werner AK, Jones CD, Fulmer EB, et al. Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement — United States, March 1–May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 4;69(35):1198–203. doi:10.15585/mmwr.mm6935a2.
  • Santoli JM, Lindley MC, DeSilva MB, Kharbanda EO, Daley MF, Galloway L, Gee J, Glover M, Herring B, Kang Y, et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration — United States, 2020. MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):591–93. doi:10.15585/mmwr.mm6919e2.
  • Patel Murthy B, Zell E, Kirtland K, Jones-Jack N, Harris L, Sprague C, Schultz J, Le Q, Bramer CA, Kuramoto S, et al. Impact of the COVID-19 pandemic on administration of selected routine childhood and adolescent vaccinations — 10 U.S. jurisdictions, March–September 2020. MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):840–45. doi:10.15585/mmwr.mm7023a2.
  • Saxena K, Marden JR, Carias C, Bhatti A, Patterson-Lomba O, Gomez-Lievano A, Yao L, Chen Y-T. Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States. Curr Med Res Opin. 2021 Dec;37(12):2077–87. doi:10.1080/03007995.2021.1981842.
  • Center for Disease Control and Prevention. National Immunization Surveys (NIS). [ accessed 2022 Jul 28]. https://www.cdc.gov/vaccines/imz-managers/nis/about.html.
  • Mansfield LN, Chung RJ, Silva SG, Merwin EI, Gonzalez-Guarda RM. Social determinants of human papillomavirus vaccine series completion among U.S. adolescents: a mixed-methods study. SSM - Popul Health. 2022 Jun;18:101082. doi:10.1016/j.ssmph.2022.101082.
  • Landis K, Bednarczyk RA, Gaydos LM. Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen. Vaccine. 2018 Jun 7;36(24):3498–504. doi:10.1016/j.vaccine.2018.04.075.
  • Choi Y, Eworuke E, Segal R. What explains the different rates of human papillomavirus vaccination among adolescent males and females in the United States? Papillomavirus Res. 2016 Dec;2:46–51. doi:10.1016/j.pvr.2016.02.001.
  • Williams CL, Walker TY, Elam-Evans LD, Yankey D, Fredua B, Saraiya M, Stokley S. Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, National Immunization Survey–Teen, 2016–2017. Hum Vaccines Immunother. 2020 Mar 3;16(3):562–72. doi:10.1080/21645515.2019.1670036.
  • Hirth JM, Fuchs EL, Chang M, Fernandez ME, Berenson AB. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008–2016). Vaccine. 2019 Jan 21;37(4):595–601. doi:10.1016/j.vaccine.2018.12.017.
  • Huang X, Lu J, Gao S, Wang S, Liu Z, Wei H. Staying at home is a privilege: evidence from fine-grained mobile phone location data in the United States during the COVID-19 pandemic. Ann Am Assoc Geogr. 2022;112(1):286–305. doi:10.1080/24694452.2021.1904819.
  • Dasgupta N, Funk M, Lazard A, White B, Marshall S. Quantifying the social distancing privilege gap: a longitudinal study of smartphone movement. medRxiv. Published Online 2020 May;8:2020.05.
  • Chiou L, Tucker C. Social distancing, internet access and inequality. 2020.
  • Czeisler M, Marynak K, Clarke KEN, Salah Z, Shakya I, Thierry JM, Ali N, McMillan H, Wiley JF, Weaver MD, et al. Delay or avoidance of medical care because of COVID-19–related concerns — United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250–57. doi:10.15585/mmwr.mm6936a4.
  • Davis AL, Sunderji A, Marneni SR, Seiler M, Hall JE, Cotanda CP, Klein EJ, Brown JC, Gelernter R, Griffiths MA, et al. Caregiver-reported delay in presentation to pediatric emergency departments for fear of contracting COVID-19: a multi-national cross-sectional study. CJEM. 2021 Nov;23(6):778–86. doi:10.1007/s43678-021-00174-z.
  • Nicholson E, McDonnell T, Conlon C, Barrett M, Cummins F, Hensey C, McAuliffe E. Parental hesitancy and concerns around accessing paediatric unscheduled healthcare during COVID-19: a cross-sectional survey. Int J Environ Res Public Health. 2020 Dec 11;17(24):9264. doi:10.3390/ijerph17249264.
  • Adams K Telehealth usage primarily driven by fear of COVID-19 transmission, survey finds. [ accessed 2022 Oct 16]. https://www.beckershospitalreview.com/telehealth/telehealth-usage-primarily-driven-by-fear-of-covid-19-transmission-survey-finds.html.
  • Darrat I, Tam S, Boulis M, Williams AM. Socioeconomic disparities in patient use of telehealth during the coronavirus disease 2019 surge. JAMA Otolaryngol–Head Neck Surg. 2021 Mar 1;147(3):287–95. doi:10.1001/jamaoto.2020.5161.
  • Katz AJ, Haynes K, Du S, Barron J, Kubik R, Chen RC. Evaluation of telemedicine use among us patients with newly diagnosed cancer by socioeconomic status. JAMA Oncol. 2022 Jan 1;8(1):161–63. doi:10.1001/jamaoncol.2021.5784.
  • Douglas-Hall A, Chau MM. Parents’ low education leads to low income, despite full-time employment. 2007.
  • Fischer SH, Ray KN, Mehrotra A, Bloom EL, Uscher-Pines L. Prevalence and characteristics of telehealth utilization in the United States. JAMA Netw Open. 2020 Oct 1;3(10):e2022302. doi:10.1001/jamanetworkopen.2020.22302.
  • Karimi M, Lee EC, Couture SJ, Gonzales A, Grigorescu V, Smith SR, De Lew N, Sommers BD. National Survey Trends in Telehealth Use in 2021: Disparities in Utilization and Audio vs. Video Services. [ accessed 2022 Sept 15]. https://aspe.hhs.gov/reports/hps-analysis-telehealth-use-2021
  • Nasserie T, Bendavid E. Systematic identification and replication of factors associated with human papillomavirus vaccine initiation among adolescents in the United States using an environment-wide association study approach. Sex Transm Infect. 2022 May;98(3):203–09. doi:10.1136/sextrans-2021-054976.
  • Oh NL, Biddell CB, Rhodes BE, Brewer NT. Provider communication and HPV vaccine uptake: a meta-analysis and systematic review. Prev Med. 2021 Jul;148:106554. doi:10.1016/j.ypmed.2021.106554.
  • Kaiser Family Foundation. Status of State Medicaid expansion decisions: interactive map. [ accessed 2022 Oct 16]. www.kff.org/medicaid/issue-brief/status-of-state-medicaid-expansion-decisions-interactive-map/.
  • Corallo BM, Sophia analysis of recent national trends in Medicaid and CHIP enrollment. [ accessed 2022 Oct 16]. https://www.kff.org/coronavirus-covid-19/issue-brief/analysis-of-recent-national-trends-in-medicaid-and-chip-enrollment/.
  • Vadaparampil ST, Kahn JA, Salmon D, Lee J-H, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine. 2011 Nov 3;29(47):8634–41. doi:10.1016/j.vaccine.2011.09.006.
  • Adjei Boakye E, Tobo BB, Rojek RP, Mohammed KA, Geneus CJ, Osazuwa-Peters N. Approaching a decade since HPV vaccine licensure: racial and gender disparities in knowledge and awareness of HPV and HPV vaccine. Human Vaccines Immunother. 2017 Nov 2;13(11):2713–22. doi:10.1080/21645515.2017.1363133.
  • Osazuwa-Peters N, Adjei Boakye E, Mohammed KA, Tobo BB, Geneus CJ, Schootman M. Not just a woman’s business! Understanding men and women’s knowledge of HPV, the HPV vaccine, and HPV-associated cancers. Prev Med. 2017 Jun;99:299–304. doi:10.1016/j.ypmed.2017.03.014.
  • Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006 Oct 15;194(8):1044–57. doi:10.1086/507432.
  • Daley EM, Vamos CA, Zimet GD, Rosberger Z, Thompson EL, Merrell L. The feminization of HPV: reversing gender biases in US human papillomavirus vaccine policy. Am J Public Health. 2016 Jun;106(6):983–84. doi:10.2105/ajph.2016.303122.
  • Maples JM, Zite NB, Oyedeji O, Chamberlin SM, Mastronardi AM, Gregory S, Gatwood JD, Hohmeier KC, Booker ME, Perry JD, et al. Availability of the HPV vaccine in regional pharmacies and provider perceptions regarding HPV vaccination in the pharmacy setting. Vaccines. 2022 Feb 24;10(3):351. doi:10.3390/vaccines10030351.
  • Osazuwa-Peters N. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States–do we need a broader vaccine policy? Vaccine. 2013 Nov 12;31(47):5500–05. doi:10.1016/j.vaccine.2013.09.031.
  • Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020 Jun 23;323(24):2458–59. doi:10.1001/jama.2020.8711.
  • Fridman A, Gershon R, Gneezy A, Capraro V. COVID-19 and vaccine hesitancy: a longitudinal study. PloS One. 2021;16(4):e0250123. doi:10.1371/journal.pone.0250123.
  • Dubé È, Ward JK, Verger P, MacDonald NE. Vaccine hesitancy, acceptance, and anti-vaccination: trends and future prospects for public health. Ann Rev Public Health. 2021 Apr 1;42(1):175–91. doi:10.1146/annurev-publhealth-090419-102240.
  • Majee W, Anakwe A, Onyeaka K, Harvey IS. The past is so present: understanding COVID-19 vaccine hesitancy among African American adults using qualitative data. J Racial Ethn Health Disparities. 2022 Feb 19;1–13. doi:10.1007/s40615-022-01236-3.